ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Quantum Genomics

Quantum Genomics (ALQGC)

0.0721
0.00
(0.00%)
Closed January 02 10:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.0721
Bid
0.072
Ask
0.1096
Volume
0.00
0.00 Day's Range 0.00
0.001 52 Week Range 0.155
Market Cap
Previous Close
0.0721
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
41,278
Shares Outstanding
69,709,954
Dividend Yield
-
PE Ratio
-2.20
Earnings Per Share (EPS)
-0.05
Revenue
36k
Net Profit
-3.17M

About Quantum Genomics

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Paris, Paris, Fra
Founded
-
Quantum Genomics is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALQGC. The last closing price for Quantum Genomics was 0.07 €. Over the last year, Quantum Genomics shares have traded in a share price range of 0.001 € to 0.155 €.

Quantum Genomics currently has 69,709,954 shares outstanding. The market capitalization of Quantum Genomics is 5.03 € million. Quantum Genomics has a price to earnings ratio (PE ratio) of -2.20.

ALQGC Latest News

Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments

Firibastat efficacy non-significant versus placeboThe REFRESH study and the development of firibastat in cardiology have been stoppedCash of 11 million euros allotted to the development of new...

Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share

PARIS, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity

PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Announces That the Results Obtained with Firibastat in its Phase III Study, FRESH Will Now be Presented on November 7, 2022, During the AHA Conference in a Session Dedicated to Resistant Hypertension

PARIS, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medications...

Quantum Genomics announces the appointment of its new Scientific Advisory Board

PARIS, June 27, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

PARIS, May 09, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs

PARIS, May 04, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update

PARIS, April 28, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Announces Successful Capital Raise with a Gross Sum of Approximately 15.6M€

Quantum Genomics has equipped itself with new financial means to pursue the development of firibastat and explore new therapeutic fields based on the patented technology platform built around...

Quantum Genomics Raises a Gross Amount of Approximately € 15 M

Launch of capital increase of approximately €15 million for institutional investors with cancellation of the pre-emptive subscription rightA minimum of €12 million subscription commitments...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.07210.07210.072100DE
4000.07210.07210.072100DE
12-0.0051-6.606217616580.07720.08780.072412780.07557478DE
26-0.0393-35.27827648110.11140.1380.0017813470.05107912DE
52-0.0339-31.98113207550.1060.1550.0014299490.05729102DE
156-4.2479-98.33101851854.324.4980.0013146380.45164116DE
260-3.4379-97.94586894593.516.1850.0013129721.86062296DE

ALQGC - Frequently Asked Questions (FAQ)

What is the current Quantum Genomics share price?
The current share price of Quantum Genomics is 0.0721 €
How many Quantum Genomics shares are in issue?
Quantum Genomics has 69,709,954 shares in issue
What is the market cap of Quantum Genomics?
The market capitalisation of Quantum Genomics is EUR 5.03M
What is the 1 year trading range for Quantum Genomics share price?
Quantum Genomics has traded in the range of 0.001 € to 0.155 € during the past year
What is the PE ratio of Quantum Genomics?
The price to earnings ratio of Quantum Genomics is -2.2
What is the cash to sales ratio of Quantum Genomics?
The cash to sales ratio of Quantum Genomics is 200
What is the reporting currency for Quantum Genomics?
Quantum Genomics reports financial results in EUR
What is the latest annual turnover for Quantum Genomics?
The latest annual turnover of Quantum Genomics is EUR 36k
What is the latest annual profit for Quantum Genomics?
The latest annual profit of Quantum Genomics is EUR -3.17M
What is the registered address of Quantum Genomics?
The registered address for Quantum Genomics is 6, RUE CAMBACERES, PARIS, PARIS, 75008
What is the Quantum Genomics website address?
The website address for Quantum Genomics is quantum-genomics.com/societe/
Which industry sector does Quantum Genomics operate in?
Quantum Genomics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DMSBSDiagnostic Medical Systems
0.0075 €
(150.00%)
1,000
ALAGOEPango SA
0.216 €
(93.55%)
13.2M
MLSMLSmalto
0.019 €
(52.00%)
33.89k
MLAAHAmatheon Agri Holding NV
0.03 €
(50.00%)
3.45k
CFNCofina SGPS SA
26.90 €
(37.95%)
4.6k
SEQUASequana medical NV
2.45 €
(-19.93%)
890.68k
FIPPFipp
0.116 €
(-17.73%)
1,000
ECTotalEnergies EP Gabon
168.50 €
(-16.58%)
30.47k
MLEFAEduformAction
0.402 €
(-16.25%)
1.1k
EIFDSTour Eiffel DS
0.0052 €
(-13.33%)
50.44k
ATOAtos SE
0.0025 €
(-3.85%)
1.49B
BCPBanco Comercial Portugues SA
0.4589 €
(-1.25%)
96.8M
ALVERVergnet
0.002 €
(0.00%)
34.56M
ALCYBCybergun
0.0001 €
(0.00%)
31.17M
ALHPIHopium SA
0.0049 €
(4.26%)
29.02M

Discussion

View Full Feed
fuagf fuagf 4 minutes ago
There were two, and yes they were "more off color than usual."
3331 3331 4 minutes ago
BIEL +50%, JANUARY EFFECT IN PLAY!
Anticipating Anticipating 4 minutes ago
Well said Man, as for the DAs,😵‍💫 They’ll see you soon enough…
SAPX
rajinka rajinka 5 minutes ago
Pretty sure he's tweetvestor3 on X if that helps you dig some more on him
SFIO
Big Hook Big Hook 5 minutes ago
All the bears here are bashing themselves. Really funny! They are the only ones here.
HMBL
JERSEYHAWG JERSEYHAWG 6 minutes ago
The email was ftom a ghost account.

The text I posted. Was from a Facebook account.

Stankonia Capital


Whoever that is. I just looked. A very active poster to. So it seems. If you can believe text and folks pics on that site. I mean who really k
LEHNQ
Investor082 Investor082 6 minutes ago
Lol. Have LP get to $2-3B valuation and stay there for a couple of weeks, as a starter. It will never happen, but I can tell you what will happen. LP, LG and the social media team will blame everyone in the world (market makers, hedge funds, big pharmas, and the list goes on) when they are unable to
NWBO
3331 3331 6 minutes ago
BIEL +50%, JANUARY EFFECT IN PLAY!
Renee Renee 6 minutes ago
EXPRQ: BK PLAN effective. All shares cancelled.

https://otce.finra.org/otce/dailyList?viewType=Deletions
EXPRQ
elks elks 6 minutes ago
Added more here today. Tic toc. Gvsi.
GVSI
Boat Shoes From Yahoo Boat Shoes From Yahoo 6 minutes ago
Warriors!  Great News! Great News! Let the PPS keep increasing, for the next 1-2  years,  as they "Work out the details" & keep providing information!  
FNMA
ElectricJester54 ElectricJester54 7 minutes ago
Ya pretty much on standby until we hear from him about Button. I think some folks are probably just holding their breath waiting to see what happens. Not that I'm not confident in it happening, but Button is the big fish and where we get a serious boost in financial potential, then audits and then u
ZHUD
Pickme2 Pickme2 7 minutes ago
I'm not into your Pump and Dump crap
ATMH
Lite Lite 8 minutes ago
C-ship should have ended six months into it - this agency needs to say it’s sorry it wronged Shareholders. Don’t want to, that’s okay - no more agency.
FNMA
Hoskuld Hoskuld 8 minutes ago
It is pretty clear, too, in the peer reviewed paper that the authors left nothing out. There was no attempt to paper over anything - to the contrary, all was brought up to the light, examined, and put in proper context with significance described. That the paper was so intellectually honest and th
AVXL
Alley-oop Alley-oop 8 minutes ago
When HMBL shares will be transferred to new company?
HMBL
newmedman newmedman 8 minutes ago
maybe you can have your mommy figure out your problem in the next 18 days.
OMOLIVES OMOLIVES 8 minutes ago
Yes and an undeniable sound. Am a huge fan of Roy as well...which is another undeniable sound:

https://www.youtube.com/watch?v=GlhBGFEi9r4
StevenRisk StevenRisk 8 minutes ago
My picks 1)ivvd 2)tcnnf 3)ai 4)curlf
The Great Pumpkin The Great Pumpkin 9 minutes ago
I don’t think any of you dyed in the wool longs understand what’s coming.

Someone does as you can see from the flash rally and sell off today.

Legal issues are mounting and you’ll hear about them soon from the proper channels.

Any rip is your chance to s
LWLG
rx7171 rx7171 9 minutes ago
I can’t find any mention of “in press”
or still a draft .
Reads to me as a finished article.
AVXL
Docsavag Docsavag 10 minutes ago
Personally, I prefer a Manhattan straight up, with Woodford Reserve...
boi568 boi568 11 minutes ago
I would expect the expertise levels between the CHMP reviewers and the co-authors of the paper to be at a similar, high level. The question then becomes, Is the evaluation of the trial for the purposes of the EMA equivalent to the evaluation of the trial for the purposes of the article?
AVXL

Your Recent History

Delayed Upgrade Clock